ERLIN1 Gene SPG62 ERLIN1 related Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for ERLIN1 Gene SPG62, ERLIN1 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ERLIN1 Gene SPG62, ERLIN1 related.
Test Details
The ERLIN1 gene is associated with a rare genetic disorder called spastic paraplegia type 62 (SPG62). SPG62 is characterized by progressive stiffness and weakness in the legs, leading to difficulty walking and sometimes additional symptoms such as intellectual disability and seizures. To diagnose SPG62, a next-generation sequencing (NGS) genetic test can be performed. This test involves sequencing the DNA of the individual to identify any mutations or variations in the ERLIN1 gene that may be causing the disorder. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of the genetic makeup.
NGS genetic testing for ERLIN1-related SPG62 can help confirm a diagnosis, guide treatment decisions, and provide information for genetic counseling. It can also be useful for identifying carriers of the gene mutation within families and providing prenatal or preimplantation genetic testing options for at-risk individuals. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing for ERLIN1-related SPG62 is appropriate and to discuss the potential benefits, limitations, and implications of the test.
Test Name | ERLIN1 Gene SPG62 ERLIN1 related Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ERLIN1 Gene SPG62, ERLIN1 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ERLIN1 Gene SPG62, ERLIN1 related |
Test Details |
The ERLIN1 gene is associated with a rare genetic disorder called spastic paraplegia type 62 (SPG62). SPG62 is characterized by progressive stiffness and weakness in the legs, leading to difficulty walking and sometimes additional symptoms such as intellectual disability and seizures. To diagnose SPG62, a next-generation sequencing (NGS) genetic test can be performed. This test involves sequencing the DNA of the individual to identify any mutations or variations in the ERLIN1 gene that may be causing the disorder. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of the genetic makeup. NGS genetic testing for ERLIN1-related SPG62 can help confirm a diagnosis, guide treatment decisions, and provide information for genetic counseling. It can also be useful for identifying carriers of the gene mutation within families and providing prenatal or preimplantation genetic testing options for at-risk individuals. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing for ERLIN1-related SPG62 is appropriate and to discuss the potential benefits, limitations, and implications of the test. |